Bach J R, Alba A S, Saporito L R
Department of Physical Medicine and Rehabilitation, University Hospital, Newark 07103.
Chest. 1993 Jan;103(1):174-82. doi: 10.1378/chest.103.1.174.
Despite wider application of the use of nocturnal intermittent positive pressure ventilation (IPPV) via nasal access for the management of nocturnal hypoventilation, there continues to be a lack of familiarity with the use of IPPV via the mouth for ventilatory support. Unlike nasal IPPV, which is generally practical only for nocturnal use, up to 24-h mouth IPPV was the key method of noninvasive ventilatory support that permitted the avoidance or elimination of tracheostomy for 257 individuals with acute or chronic ventilatory failure. Mouth IPPV was delivered via commercially available mouthpieces for daytime aid and mouthpiece with lip seal or custom orthodontic interfaces for nocturnal support. The use of mouth IPPV alone or in a regimen with other noninvasive ventilatory aids was reviewed for these 257 individuals. Mouth IPPV was used for nocturnal aid by 163 individuals, 61 of whom had little or no measurable vital capacity or significant ventilator-free breathing time, for more than 1,560 patient-years with few complications. It was also the predominant method of daytime ventilatory support for 228 individuals for more than 2,350 patient-years. We conclude that for individuals with adequate bulbar muscle function but chronic respiratory muscle insufficiency, mouth IPPV can be an effective alternative to tracheostomy. It can significantly prolong survival while optimizing convenience, safety, and communication.
尽管夜间经鼻间歇性正压通气(IPPV)在治疗夜间通气不足方面得到了更广泛的应用,但人们对经口使用IPPV进行通气支持仍缺乏了解。与通常仅适用于夜间使用的经鼻IPPV不同,长达24小时的经口IPPV是无创通气支持的关键方法,使得257例急性或慢性呼吸衰竭患者避免或无需进行气管造口术。经口IPPV通过市售的口含器用于日间辅助,通过带唇密封的口含器或定制的正畸接口用于夜间支持。对这257例患者使用经口IPPV单独或与其他无创通气辅助设备联合使用的情况进行了回顾。163例患者使用经口IPPV进行夜间辅助,其中61例肺活量极小或无法测量,或无明显的自主呼吸时间,在超过1560患者年的时间里并发症很少。它也是228例患者超过2350患者年的主要日间通气支持方法。我们得出结论,对于延髓肌肉功能正常但存在慢性呼吸肌无力的患者,经口IPPV可以作为气管造口术的有效替代方法。它可以显著延长生存期,同时优化便利性、安全性和沟通能力。